Edgar Lomax CO Pfizer Inc Transaction History

Edgar Lomax CO

$1.63 Billion
Q3 2024

A detailed history of Edgar Lomax CO transactions in Pfizer Inc stock. As of the latest transaction made, Edgar Lomax CO holds 1,468,800 shares of PFE stock, worth $38.7 Million. This represents 2.61% of its overall portfolio holdings.

Number of Shares

1,468,800

Previous 1,492,125 1.56%

Holding current value

$38.7 Million

Previous $41.7 Million 1.82%

% of portfolio

2.61%

Previous 2.72%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $646,102 - $732,171	-23,325 Reduced 1.56%	1,468,800 $42.5 Million
Q2 2024 Aug 13, 2024	SELL	$25.26 - $29.6 $479,687 - $562,104	-18,990 Reduced 1.26%	1,492,125 $41.7 Million
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $14.6 Million - $16.7 Million	562,791 Added 59.35%	1,511,115 $41.9 Million
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $1.13 Million - $1.47 Million	-43,329 Reduced 4.37%	948,324 $27.3 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $576,079 - $673,379	-17,952 Reduced 1.78%	991,653 $32.9 Million
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $504,054 - $583,179	-13,955 Reduced 1.36%	1,009,605 $37 Million
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $2.05 Million - $2.67 Million	-52,060 Reduced 4.84%	1,023,560 $41.8 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $261,981 - $341,987	-6,275 Reduced 0.58%	1,075,620 $55.1 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $14.4 Million - $17.6 Million	330,040 Added 43.9%	1,081,895 $47.3 Million
Q2 2022 Aug 10, 2022	BUY	$46.53 - $55.17 $972,477 - $1.15 Million	20,900 Added 2.86%	751,855 $39.4 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $1.59 Million - $1.97 Million	-34,760 Reduced 4.54%	730,955 $37.8 Million
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $304,321 - $451,106	-7,365 Reduced 0.95%	765,715 $45.2 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $606,805 - $779,493	-15,460 Reduced 1.96%	773,080 $33.3 Million
Q2 2021 Aug 09, 2021	SELL	$35.91 - $40.68 $469,164 - $531,484	-13,065 Reduced 1.63%	788,540 $30.9 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $33.9 Million - $38.3 Million	-1,013,555 Reduced 55.84%	801,605 $29 Million
Q4 2020 Feb 11, 2021	SELL	$33.47 - $42.56 $1.14 Million - $1.44 Million	-33,952 Reduced 1.84%	1,815,160 $66.8 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $2.26 Million - $2.66 Million	71,300 Added 4.01%	1,849,112 $67.9 Million
Q2 2020 Aug 12, 2020	BUY	$30.12 - $36.54 $1.05 Million - $1.28 Million	34,922 Added 2.0%	1,777,812 $58.1 Million
Q1 2020 May 14, 2020	BUY	$27.03 - $38.62 $8.53 Million - $12.2 Million	315,425 Added 22.1%	1,742,890 $56.9 Million
Q4 2019 Feb 11, 2020	SELL	$32.92 - $37.36 $872,281 - $989,927	-26,497 Reduced 1.82%	1,427,465 $55.9 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $516,591 - $669,867	-15,900 Reduced 1.08%	1,453,962 $52.2 Million
Q2 2019 Aug 09, 2019	SELL	$36.98 - $41.52 $835,747 - $938,352	-22,600 Reduced 1.51%	1,469,862 $63.7 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $2.94 Million - $3.24 Million	-78,525 Reduced 5.0%	1,492,462 $63.4 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $941,553 - $1.07 Million	-24,475 Reduced 1.53%	1,570,987 $68.6 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $1.97 Million - $2.39 Million	-57,235 Reduced 3.46%	1,595,462 $70.3 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $385,865 - $411,371	11,700 Added 0.71%	1,652,697 $60 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $10.6 Million - $12.3 Million	332,791 Added 25.44%	1,640,997 $58.2 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $1.33 Million - $1.41 Million	-40,090 Reduced 2.97%	1,308,206 $47.4 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $41.8 Million - $46 Million	1,348,296	1,348,296 $48.1 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgar Lomax CO, based on Form 13F filings with the SEC.

News

Stay updated on Edgar Lomax CO with notifications on news.

Account